Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: Results of a double-blind, randomised study - Commentary

Tom Huizinga; Peter Nigrovic; Eric Ruderman; Hendrik Schulze-Koops

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: Results of a double-blind, randomised study - Commentary

Tom Huizinga^*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

^*Corresponding author for this work

Medicine, Rheumatology Division

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Number of pages	1
Journal	International Journal of Advances in Rheumatology
Volume	9
Issue number	4
State	Published - Dec 1 2011

ASJC Scopus subject areas

Rheumatology

Cite this

@article{84b2fb3e34b44d00bdee0028c9cec348,

title = "Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: Results of a double-blind, randomised study - Commentary",

author = "Tom Huizinga and Peter Nigrovic and Eric Ruderman and Hendrik Schulze-Koops",

year = "2011",

month = dec,

day = "1",

language = "English (US)",

volume = "9",

journal = "International Journal of Advances in Rheumatology",

issn = "1478-856X",

publisher = "Remedica Medical Education and Publishing Ltd",

number = "4",

}

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: Results of a double-blind, randomised study - Commentary. / Huizinga, Tom; Nigrovic, Peter; Ruderman, Eric et al.
In: International Journal of Advances in Rheumatology, Vol. 9, No. 4, 01.12.2011.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment

T2 - Results of a double-blind, randomised study - Commentary

AU - Huizinga, Tom

AU - Nigrovic, Peter

AU - Ruderman, Eric

AU - Schulze-Koops, Hendrik

PY - 2011/12/1

Y1 - 2011/12/1

UR - http://www.scopus.com/inward/record.url?scp=84863894085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863894085&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:84863894085

SN - 1478-856X

VL - 9

JO - International Journal of Advances in Rheumatology

JF - International Journal of Advances in Rheumatology

IS - 4

ER -

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: Results of a double-blind, randomised study - Commentary

ASJC Scopus subject areas

Other files and links

Cite this